secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2026-07-17T20:34:51+00:00
Accession:  0001640334-26-001198
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences shareholders approve increase in authorized shares and share issuance at 2026 annual meeting
--------------------------------------------------------------------------------

- Three Class III directors re-elected: Reyes (179,416 for), Favorito (176,821), Gorgas (171,567); broker non-votes 937,382.
- Amendment to increase authorized common stock from 166,666,667 to 500,000,000 approved: 985,717 for, 164,845 against, 21,641 abstain.
- Share issuance >20% under Equity Purchase Agreement with Square Gate Capital Master Fund approved: 91,158 for, 65,155 against, 78,508 abstain, 937,382 broker non-votes.
- Approximately 41.2% of outstanding shares (1,172,203 of 2,848,540) represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426001198/0001640334-26-001198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426001198/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-001198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer